SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-17-000816
Filing Date
2017-01-31
Accepted
2017-01-31 17:02:15
Documents
13

Document Format Files

Seq Description Document Type Size
1 AMENDED REGISTRATION STATEMENT posam2016a3_biondvax.htm POS AM 6501584
2 GRAPHIC image001.jpg GRAPHIC 200398
3 GRAPHIC image002.jpg GRAPHIC 513572
4 GRAPHIC image003.jpg GRAPHIC 401783
5 GRAPHIC image004.jpg GRAPHIC 254594
6 GRAPHIC image005.jpg GRAPHIC 268587
7 GRAPHIC image006.jpg GRAPHIC 384508
8 GRAPHIC image007.jpg GRAPHIC 720295
9 GRAPHIC image008.jpg GRAPHIC 777664
10 GRAPHIC image009.jpg GRAPHIC 848674
11 GRAPHIC image010.jpg GRAPHIC 272637
12 GRAPHIC image011.jpg GRAPHIC 323148
13 GRAPHIC image012.jpg GRAPHIC 4629
  Complete submission text file 0001213900-17-000816.txt   13340321
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: POS AM | Act: 33 | File No.: 333-201283 | Film No.: 17561877
SIC: 2836 Biological Products, (No Diagnostic Substances)